COLLETTE BROWN: Open Payments
NPI 1003427899 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,987 in 103 payments from 26 companies in 2025. Trend: 2023 $3,303 · 2024 $1,661 · 2025 $1,987
Food & beverage: $1,987
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $227 |
| Dexcom, Inc. | 10 | $190 |
| Tandem Diabetes Care, Inc. | 7 | $143 |
| Amgen Inc. | 8 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $117 |
| Corcept Therapeutics | 6 | $112 |
| Lilly USA, LLC | 6 | $94 |
| RECORDATI_RARE_DISEASES_INC. | 5 | $90 |
| Xeris Pharmaceuticals, Inc. | 5 | $88 |
| ABBVIE INC. | 4 | $85 |
Products named: Dexcom G6 Transmitter, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Kerendia, Korlym, TEPEZZA, MOUNJARO, ISTURISA.
Industry payments across LA — which companies pay providers there.
